McCammon R L, Hilgenberg J C, Stoelting R K
Anesth Analg. 1981 Aug;60(8):579-83.
The present study evaluated the hemodynamic effects produced by the intravenous infusion of diazepam (0.5 mg/kg over 10 minutes) and the simultaneous inhalation of 50% nitrous oxide in oxygen administered to 19 patients with coronary artery disease who were receiving chronic propranolol therapy (106 +/- 67 mg/day). In addition, hemodynamic changes produced by direct laryngoscopy and intubation of the trachea were measured. Data during the induction of anesthesia were compared to measurements obtained in a previously reported group of similar patients anesthetized in the same manner but not receiving propranolol. In the present study, as in previously observed patients not receiving propranolol, induction of anesthesia with diazepam-nitrous oxide did not result in any significant change from awake measurements with respect to heart rate (HR), mean arterial pressure (MAP), or rate-pressure product (RPP). Cardiovascular responses were similar in patients with awake resting heart rates greater than 70 beats per minute (nine patients) and less than 70 beats pr minute (10 patients). This suggests that propranolol does not alter the benign hemodynamic effects produced by this type of induction of anesthesia. Laryngoscopy and tracheal intubation significantly (p less than 0.01) increased MAP at 1 minute and HR and RPP at 1 and 2 minutes after the start of laryngoscopy. These changes were transient, returning to control values within 3 minutes after intubation. Patients with awake resting HR less than 70 beats per minute had greater increases in HR and RPP at 1 minute than did patients with resting HR greater than 70 beats per minute (p less than 0.05). This suggests that propranolol even in doses adequate to produce significant slowing of HR in awake patients does not ensure protection against increases in HR and MAP associated with laryngoscopy and intubation of the trachea.
本研究评估了静脉输注地西泮(10分钟内输注0.5mg/kg)并同时吸入50%氧化亚氮与氧气混合气体对19例接受慢性普萘洛尔治疗(106±67mg/天)的冠心病患者产生的血流动力学效应。此外,还测量了直接喉镜检查和气管插管引起的血流动力学变化。将麻醉诱导期间的数据与先前报道的一组以相同方式麻醉但未接受普萘洛尔治疗的类似患者所获得的测量值进行比较。在本研究中,与先前观察的未接受普萘洛尔治疗的患者一样,用地西泮-氧化亚氮诱导麻醉后,心率(HR)、平均动脉压(MAP)或心率-压力乘积(RPP)与清醒时测量值相比无任何显著变化。清醒静息心率大于70次/分钟的患者(9例)和小于70次/分钟的患者(10例)的心血管反应相似。这表明普萘洛尔不会改变这种麻醉诱导方式产生的良性血流动力学效应。喉镜检查和气管插管显著(p<0.01)增加了喉镜检查开始后1分钟时的MAP以及1分钟和2分钟时的HR和RPP。这些变化是短暂的,插管后3分钟内恢复至对照值。清醒静息HR小于70次/分钟的患者在1分钟时HR和RPP的增加幅度大于静息HR大于70次/分钟的患者(p<0.05)。这表明即使普萘洛尔的剂量足以使清醒患者的HR显著减慢,也不能确保预防与喉镜检查和气管插管相关的HR和MAP升高。